questionText: To ask the Secretary of State for Health and Social Care, whether her Department has received recent representations from relevant stakeholders on the occurrence of post-selective serotonin reuptake inhibitor sexual dysfunction arising from anti-depressan
answerText: The Medicines and Healthcare products Regulatory Agency receives reports of suspected side effects for medicines, including reports related to sexual dysfunction associated with antidepressants, through the Yellow Card Scheme, from patients and healthcare...
heading: Selective Serotonin Reuptake Inhibitors: Sexual Dysfunction